Half the amount of chemo prevents testicular cancer from returning, new trial shows

Testicular cancer can be prevented from coming back using half the amount of chemotherapy that is currently used, a new clinical trial has shown.

In many men who have had surgery for an aggressive form of testicular cancer, the disease can come back elsewhere in their bodies and need intensive treatment, often within two years after initial diagnosis.

The new trial showed that giving men one cycle of chemotherapy was as effective at preventing men’s testicular cancer from coming back as the two cycles used as standard.